VascuChek also offers a variety of other vascular screening advantages like cordless freedom and improved user control and reliability
Remington Medical announced the launch of VascuChek. (Credit: Narupon Promvichai from Pixabay)
Remington Medical, a medical device manufacturing company based in the U.S., announced the launch of VascuChek, the industry’s first modern wireless, handheld vascular Doppler device for surgical and clinical use.
More than four years ago, company leaders took a deep dive into the functionality of a vascular Doppler device that had been used by top surgeons and clinicians for decades.
“Our team realized that traditional vascular equipment has an extensive list of inefficiencies, including long cables, poor quality speakers, and an unreliable battery source, to name a few,” said Attly Aycock, CEO of Remington. “After reviewing the list of flaws that came with traditional vascular equipment, it was clear that the healthcare industry had an urgent need for a new and improved way to assess patient blood flow more effectively.”
Multiple prototypes were created, and after choosing a design that exceeded expectations, the team interviewed more than 100 of the nation’s top physicians and surgeons to ask if the vascular Doppler device would be a valuable addition to the market. The results were reviewed, and there was no doubt that the healthcare industry would benefit from a Remington vascular Doppler product.
Developed alongside more than 100 clinicians, Remington is proud to announce the launch of the VascuChek Doppler System, the company’s first innovation in Doppler medical equipment for clinical and surgical vascular procedures.
Remington’s VascuChek is designed and manufactured with a continuous 9 MHz wave system and takes up a fraction of the space of current Doppler system technology by eliminating the use of a large transceiver box with tethered probes and restrictive cords.
VascuChek also offers a variety of other vascular screening advantages like cordless freedom and improved user control and reliability. VascuChek is intended for the intraoperative and transcutaneous evaluation of blood flow in a wide range of applications like intraoperative (microvascular and vascular), neurological, and peripheral vascular. VascuChek is also intended for the non-invasive transcutaneous evaluation of blood flow.
Headquartered at 6830 Meadowridge Court in Alpharetta, Georgia, Remington looks forward to providing VascuChek to top hospitals and medical centers throughout the U.S. and Canada.
Source: Company Press Release